ATE211924T1 - Verfahren zur herstellung von facial metall tricarbonyl verbindungen und ihre anwendung zur markierung von biosubstraten - Google Patents

Verfahren zur herstellung von facial metall tricarbonyl verbindungen und ihre anwendung zur markierung von biosubstraten

Info

Publication number
ATE211924T1
ATE211924T1 AT98918501T AT98918501T ATE211924T1 AT E211924 T1 ATE211924 T1 AT E211924T1 AT 98918501 T AT98918501 T AT 98918501T AT 98918501 T AT98918501 T AT 98918501T AT E211924 T1 ATE211924 T1 AT E211924T1
Authority
AT
Austria
Prior art keywords
compound
preparation
water
biosubstrates
marking
Prior art date
Application number
AT98918501T
Other languages
English (en)
Inventor
Roger Alberto
Roger Schibli
Andre Egli
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Application granted granted Critical
Publication of ATE211924T1 publication Critical patent/ATE211924T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0474Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0476Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from monodendate ligands, e.g. sestamibi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0474Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01GCOMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G45/00Compounds of manganese
    • C01G45/04Carbonyls
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01GCOMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G99/00Subject matter not provided for in other groups of this subclass
    • C01G99/006Compounds containing, besides a metal not provided for elsewhere in this subclass, two or more other elements other than oxygen or hydrogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/004Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005Compounds without a metal-carbon linkage
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00Physical properties of inorganic compounds
    • C01P2006/88Isotope composition differing from the natural occurrence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT98918501T 1997-04-25 1998-04-21 Verfahren zur herstellung von facial metall tricarbonyl verbindungen und ihre anwendung zur markierung von biosubstraten ATE211924T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97201232A EP0879606A1 (de) 1997-04-25 1997-04-25 Verfahren zur Herstellung von facial Metall Tricarbonyl Verbindungen und ihre Anwendung zur Markierung von Biosubstraten
PCT/US1998/007979 WO1998048848A1 (en) 1997-04-25 1998-04-21 Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates

Publications (1)

Publication Number Publication Date
ATE211924T1 true ATE211924T1 (de) 2002-02-15

Family

ID=8228251

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98918501T ATE211924T1 (de) 1997-04-25 1998-04-21 Verfahren zur herstellung von facial metall tricarbonyl verbindungen und ihre anwendung zur markierung von biosubstraten

Country Status (18)

Country Link
EP (2) EP0879606A1 (de)
JP (1) JP4357597B2 (de)
KR (1) KR100579168B1 (de)
AT (1) ATE211924T1 (de)
AU (1) AU748213B2 (de)
BR (1) BR9809409B1 (de)
CA (1) CA2282563C (de)
CZ (1) CZ295214B6 (de)
DE (1) DE69803205T2 (de)
DK (1) DK1019095T3 (de)
ES (1) ES2168751T3 (de)
HU (1) HU225487B1 (de)
IL (1) IL131658A (de)
NO (1) NO995160L (de)
NZ (1) NZ337303A (de)
PL (1) PL189514B1 (de)
PT (1) PT1019095E (de)
WO (1) WO1998048848A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19860289C2 (de) * 1998-12-21 2003-11-13 Schering Ag Neue Chelatoren sowie deren Tricarbonyl-Komplexe mit Technetium und Rhenium
EP1021074B1 (de) 1999-01-15 2012-06-20 The Boeing Company Cockpit-Halbleiterplatten und deren Komponenten
JP2002537360A (ja) * 1999-02-24 2002-11-05 マリンクロッド・インコーポレイテッド 腫瘍の処置用および診断用の分子
US6844425B1 (en) 1999-02-24 2005-01-18 Mallinckrodt Inc. Combination of intercalating organometallic complexes and tumor seeking biomolecules for DNA cleavage and radiotherapy
WO2001000637A1 (en) * 1999-06-29 2001-01-04 Mallinckrodt Inc. Group (vii) transition-metal complexes with multidentate aminopolycarboxylate ligands and a kit for producing them
US6926883B1 (en) * 1999-06-29 2005-08-09 Mallinckrodt Inc Group (VII) transition-metal complexes with multidentate aminopolycarboxylate ligands and a kit for producing them
AUPQ262499A0 (en) 1999-09-02 1999-09-23 University Of Queensland, The Novel iron chelators
AU783079B2 (en) * 1999-10-05 2005-09-22 Mallinckrodt Llc Carbon monoxide source for preparation of transition-metal-carbonyl-complexes
US6359119B1 (en) * 2000-05-24 2002-03-19 Mallinckrodt Inc. Formulation of Tc and Re carbonyl complexes using stannous ion as the reductant for pertechnetate and perrhenate
JP5448284B2 (ja) * 2000-06-02 2014-03-19 ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム エチレンジシステイン(ec)−薬物結合体
CN1136921C (zh) * 2001-04-27 2004-02-04 北京师范大学 一种心肌显像剂及其制备方法
GB0111872D0 (en) 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
US7011854B2 (en) 2002-02-04 2006-03-14 Alfama-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof
KR100445971B1 (ko) * 2002-04-15 2004-08-25 한국원자력연구소 수소화붕소 교환수지를 이용한 테크네튬 또는 레늄의표지방법
ES2323364T3 (es) * 2002-09-03 2009-07-14 University Of Zurich Preparacion de complejos m(co)3 con tecnicas de fase solida mediante corte metalico desde el soporte solido.
GB2395432B (en) * 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
US7682601B2 (en) 2003-04-15 2010-03-23 Mallinckrodt Inc. Bifunctional tridentate pyrazolyl containing ligands for re and tc tricarbonyl complexes
ATE470456T1 (de) 2003-04-15 2010-06-15 Mallinckrodt Inc Bifunktionale tridentate pyrazolyl-enthaltende liganden für re-, tc- und mn- tricarbonyl- komplexe
KR20060003064A (ko) * 2003-04-29 2006-01-09 유니베르시태트 취리히 〔M(OH2)3(CO)3〕+로의 FAC 배위에 의한매우 효과적인 표지를 위해 생체분자로 커플링되는, Nε및(또는)Nα 유도체화, 금속 및 유기 보호 L-히스티딘
WO2006026855A1 (en) * 2004-09-07 2006-03-16 Triumf, Operating As A Joint Venture By The Governors Of The University Of Alberta, The University Of British Columbia, Carleton Synthesis of radiolabeled sugar metal complexes
JP2008037752A (ja) * 2004-11-19 2008-02-21 Nihon Medi Physics Co Ltd 新規放射性テクネチウム−ビスホスフィノアミン錯体および該錯体を含む放射性画像診断剤
KR100650506B1 (ko) * 2005-12-16 2006-11-30 한국원자력연구소 방사성 의약품용 레늄-트리카보닐 착물 및 그 전구체의제조방법
US10925977B2 (en) 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
GB0623482D0 (en) 2006-11-24 2007-01-03 Mallinckrodt Inc Technetium-99m (l) tricarbonyl complexes with tridentate chelators for myocardium imaging
DE102010014412A1 (de) 2010-04-08 2012-04-19 Friedrich-Schiller-Universität Jena Verwendung von zweikernigen Eisenkomplexen mit schwefelhaltigen Liganden als pharmakologische Wirkstoffe
DE102010014411A1 (de) 2010-04-08 2011-10-13 Friedrich-Schiller-Universität Jena Kohlenmonoxid und Eisen freisetzende Moleküle, deren Verwendung und Verfahren zu deren Herstellung
WO2012145520A2 (en) 2011-04-19 2012-10-26 Alfama, Inc. Carbon monoxide releasing molecules and uses thereof
WO2013013179A1 (en) 2011-07-21 2013-01-24 Alfama, Inc. Ruthenium carbon monoxide releasing molecules and uses thereof
DE102012004132A1 (de) 2012-02-29 2013-08-29 Friedrich-Schiller-Universität Jena Kohlenstoffmonoxid freisetzende Materialien und deren Verwendung
KR101200049B1 (ko) * 2012-05-14 2012-11-13 한국원자력연구원 테크네튬-99엠 트리카보닐 표지 글리신 단량체 또는 올리고머 활용 생리활성분자를 이용한 프로브의 제조방법 및 이를 포함하는 영상제 조성물
DE102014008537A1 (de) 2014-06-04 2015-12-17 Friedrich-Schiller-Universität Jena Wasserlösliche manganbasierte Kohlenstoffmonoxid freisetzende Moleküle, deren Verwendung und Verfahren zu deren Herstellung
RU2708076C1 (ru) * 2019-09-10 2019-12-04 федеральное государственное автономное образовательное учреждение высшего образования «Национальный исследовательский Томский политехнический университет» Способ получения комплекса технеция-99м с производным октреотида для диагностики нейроэндокринных опухолей

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2533570B1 (fr) * 1982-09-23 1985-07-12 Centre Nat Rech Scient Complexes organometalliques d'oestrogenes et leur application au dosage des recepteurs hormonaux

Also Published As

Publication number Publication date
NO995160D0 (no) 1999-10-22
JP2002512616A (ja) 2002-04-23
EP0879606A1 (de) 1998-11-25
EP1019095B1 (de) 2002-01-16
DE69803205D1 (de) 2002-02-21
CZ295214B6 (cs) 2005-06-15
HU225487B1 (en) 2006-12-28
KR100579168B1 (ko) 2006-05-12
EP1019095A1 (de) 2000-07-19
CA2282563A1 (en) 1998-11-05
CA2282563C (en) 2007-12-04
IL131658A (en) 2004-12-15
DE69803205T2 (de) 2002-09-19
AU7141398A (en) 1998-11-24
BR9809409A (pt) 2000-06-13
WO1998048848A1 (en) 1998-11-05
HUP0003255A3 (en) 2003-06-30
IL131658A0 (en) 2001-01-28
PT1019095E (pt) 2002-07-31
DK1019095T3 (da) 2002-05-06
KR20010020298A (ko) 2001-03-15
PL189514B1 (pl) 2005-08-31
NO995160L (no) 1999-12-13
AU748213B2 (en) 2002-05-30
JP4357597B2 (ja) 2009-11-04
BR9809409B1 (pt) 2008-11-18
HUP0003255A2 (hu) 2001-02-28
PL336382A1 (en) 2000-06-19
CZ9903751A3 (en) 2001-05-16
ES2168751T3 (es) 2002-06-16
NZ337303A (en) 2000-12-22

Similar Documents

Publication Publication Date Title
ATE211924T1 (de) Verfahren zur herstellung von facial metall tricarbonyl verbindungen und ihre anwendung zur markierung von biosubstraten
US6126916A (en) Radiometal-binding peptide analogues
Maibaum et al. A facile synthesis of statine and analogs by reduction of. beta.-keto esters derived from Boc-protected amino acids. HPLC analyses of their enantiomeric purity
KR900009697A (ko) 펩티드 유도체
EP0420934B1 (de) Bifunktionelle kuppler und daraus hergestellte mit radionukleid markierte zusammensetzungen
KR970703171A (ko) 영상화용 테크네튬-99m 표지화 펩티드(TECHNETIUM-99M LABELED PEPTIDES FOR IMAGING)
ATE86964T1 (de) Malonsaeurederivate und ihre synthesemethoden.
KR960010683A (ko) 소마토스타틴 펩타이드, 이의 제법 및 이를 함유하는 약학적 조성물
JP2005529166A (ja) ペプチドカップリングのための試薬の化学合成
JPS58116443A (ja) 新規ペプチドおよびその製法
DE69715860T2 (de) Verfahren zur herstellung von peptiden
Zarezin et al. Diazocarbonyl derivatives of amino acids: unique chiral building blocks for the synthesis of biologically active compounds
Bentley et al. Qualitative determination of N-terminal amino acids of peptides and proteins with cobalt (III) chelates
DE69834929D1 (de) Verwendung eines organspezifischen ernährungmittels
KR960703612A (ko) 면역계 및 중추 신경계 치료용 신규의 트리펩티드(novel tripeptides useful in immune and cns therapy)
Okarvi et al. Comparison of the labelling characteristics of mercaptoacetyltriglycine (MAG3) with different S‐protective groups
KR100755935B1 (ko) 히스티딘 유도체 및 이를 이용한 금속 트리카보닐 착화물,이들의 제조방법 및 이들을 포함하는 조영제
Pohlmann et al. Synthesis and conformational analysis of two 2‐oxopiperazine‐containing tetrapeptide analogues
KR900701830A (ko) 신규의 펜타펩티드 및 그의 제조방법
DE69428401T2 (de) Verfahren zur Herstellung von alpha-Aminosäureamiden zur Verwendung in der Peptidsynthese
JP3397905B2 (ja) グアニジン誘導体及びその製造法
Lee et al. Efficient synthesis of a new amino acid,(2S, 3R, 4R)-4-chloro-3-hydroxyproline.
Ehrenkaufer et al. Stereo and regioselectivity in''Activated''tritium reactions
Reid et al. The Synthesis of Labeled Alpha Amino Acids:(UCRL-408)
CZ280679B6 (cs) Způsob izotopového značení peptidů

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification